The folic acid–deferrioxamine B–gallium(III) system
was assembled on the gold–mercaptopropionic acid surface through
an effective method for the first time; then, the assembled nanobioconjugated
system, Au-MPA-FOA-DFO-Ga(III), was successfully tested for capturing
of the mouse breast cancer cells 4T1. Physicochemical characteristics
of the constructed system were studied by attenuated total reflectance
Fourier transform infrared spectroscopy, X-ray photoelectron spectroscopy,
cyclic and differential pulse voltammetry, and electrochemical impedance
spectroscopy (EIS). To evaluate the capturing ability of the folate
receptor (FR) expressed cancer cells by the prepared system, the 4T1
cells were tested as a model of FR-expressed cells, and the human
foreskin fibroblast cells were tested as a model of no FR-expressed
cells. The presence of cancer cells on the system surface was successfully
detected by EIS based on variations of the charge-transfer resistance
(R
ct) of the [Fe(CN)6]3–/4– redox probe at the Au-MPA-FOA-DFO-Ga(III)
electrode system/solution interface. Large variations observed in
the R
ct of the electrode, from 30.26 ±
0.04 to 227.50 ± 0.02 kΩ, supported the high affinity of
the Au-MPA-FOA-DFO-Ga(III) system for 4T1 cells. Accumulation of the
4T1 cells onto the system surface was found to be time-dependent.
The modified electrode exhibited rapid uptake kinetics for 4T1 cells
with a t
1/2 of ∼8.5 min. The experimental
results are presented and discussed in this paper.